For the benefit of moms with preemie babies
Our Mission is to provide education and resources to moms with preemie babies suffering with NEC, ROP, or CP conditions.
Our DESIRE
Our PURPOSE
Our PURPOSE
Our desire is to provide education, information, tools, resources, and even financial relief to the mothers with premature babies who suffer from necrotizing enterocolitis, retinopathy of prematurity, and cerebral palsy as a result of consuming cow milk-based formula. If you are affected by this crisis, we want you to get the help you need. We are a qualified 501(c)(3) charitable organization.
Our PURPOSE
Our PURPOSE
Our PURPOSE
We recognized the need for aggressive and energetic nonprofit work in this underserved area. It is important to help families struggling with the challenges associated with preemie babies suffering with necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) and cerebral palsy (CP) and other ailments.
The organization was formed
We recognized the need for aggressive and energetic nonprofit work in this underserved area. It is important to help families struggling with the challenges associated with preemie babies suffering with necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) and cerebral palsy (CP) and other ailments.
The organization was formed with the purpose of fostering cooperation and mobilizing action to help moms and preemie babies to survive and thrive.
Our Mission
Our PURPOSE
Our Mission
Our members and volunteers provide the focus and momentum necessary to raise awareness and provide valuable resources to affect positive effects. Using data driven models, we provide solutions that make long-lasting differences to the injured and their families..
Benefit a Mom with a Preemie baby
Help Our Cause
$400.00
Your Generous contributions will enable us to meet our national goals of providing timely information, resources, and financial relief to moms with preemie babies.. We anticipate that a $400 contribution can provide a minimum level of temporary assistance to a mom with a preemie baby suffering with necrotizing enterocolitis, retinopathy of prematurity, or cerebral palsy. Contact us directly to make your contribution.
Site Content
Additional Information
Consider the Following:
I. Introduction
Necrotizing enterocolitis (NEC) is a serious medical condition that can occur in premature infants, where a portion of the intestine becomes inflamed and starts to die. It is a life-threatening condition that requires immediate medical attention. Recent research has suggested that the consumption of certain types of baby formula may increase the risk of developing NEC in infants, leading to concern among parents and healthcare providers.
The purpose of this article is to provide an overview of the NEC lawsuit and its potential link to baby formula consumption. It will also examine the recent settlement for the baby formula lawsuit and the specific formulas involved in the lawsuit. Additionally, the article will explore the symptoms of NEC and the reasoning behind the use of corn syrup in baby formula. By discussing these topics, this article aims to educate parents and healthcare providers about the potential risks associated with baby formula consumption and the steps that can be taken to minimize these risks.
II. NEC Lawsuit Overview
The NEC lawsuit is a legal action brought by parents and families of infants who have developed necrotizing enterocolitis after consuming certain types of baby formula. The lawsuit alleges that the manufacturers of these baby formulas failed to adequately warn consumers of the potential risks associated with their products.
The NEC lawsuit entails a class action lawsuit that seeks compensation for medical expenses, pain and suffering, and other damages resulting from the development of NEC in infants. The lawsuit also aims to hold the manufacturers of these formulas accountable for their actions and to push for improved regulations in the baby formula industry.
The timeline of the NEC lawsuit goes back several years, with the first cases being reported in 2016. Since then, more families have come forward with similar claims, leading to a growing number of lawsuits against baby formula manufacturers. The NEC lawsuit is ongoing, and new developments are expected to emerge in the coming months and years.
III. Settlement for Baby Formula Lawsuit
In November 2020, a settlement was reached in a lawsuit against baby formula manufacturers that had been accused of causing infants to develop necrotizing enterocolitis. The settlement was valued at $26 million and was to be split among eligible families who had filed a claim.
The settlement provides compensation for medical expenses, pain and suffering, and other damages resulting from the development of NEC in infants. The amount of compensation awarded to each family will depend on the severity of the child's condition and the extent of the damages suffered.
To be eligible for the settlement, families must have purchased and fed their infant certain types of baby formula that have been linked to NEC. They must also have a child who was diagnosed with NEC and received medical treatment as a result. Families who meet these criteria can file a claim to receive compensation from the settlement.
It is important to note that the settlement does not require baby formula manufacturers to admit any fault or wrongdoing. However, it does provide some measure of relief for families who have been impacted by NEC and serves as a reminder of the potential risks associated with baby formula consumption.
IV. Formulas Involved in the NEC Lawsuit
Several baby formula brands have been linked to an increased risk of necrotizing enterocolitis in infants. These include:
- Enfamil
- Similac
- Gerber Good Start
- Parent's Choice
- Up & Up
These formulas contain certain ingredients that have been identified as potentially harmful to infants. One such ingredient is corn syrup, which is often used as a sweetener in baby formulas. Corn syrup can be difficult for infants to digest and has been linked to an increased risk of developing NEC.
Other ingredients that have been implicated in the development of NEC include soybean oil and palm oil. These oils are commonly used in baby formulas to provide essential fatty acids and other nutrients. However, they may also contribute to inflammation in the intestine and increase the risk of developing NEC.
It is important to note that not all baby formulas contain these ingredients, and not all infants who consume these formulas will develop NEC. However, parents and healthcare providers should be aware of the potential risks associated with these formulas and consider alternative options when possible.
V. Class Action Lawsuit Against Similac
In 2019, a class action lawsuit was filed against Abbott Laboratories, the manufacturer of Similac baby formula. The lawsuit alleged that certain varieties of Similac formula contained ingredients that increased the risk of developing necrotizing enterocolitis in infants.
The lawsuit was brought on behalf of parents and families of infants who had been diagnosed with NEC after consuming Similac formula. The plaintiffs sought compensation for medical expenses, pain and suffering, and other damages resulting from the development of NEC.
In 2020, a settlement was reached in the class action lawsuit against Similac. The settlement was valued at $49.75 million and was to be split among eligible families who had filed a claim.
The settlement provided compensation for medical expenses, pain and suffering, and other damages resulting from the development of NEC in infants who had consumed certain varieties of Similac formula. The amount of compensation awarded to each family depended on the severity of the child's condition and the extent of the damages suffered.
The Similac settlement is one of the largest payouts in a class action lawsuit involving baby formula. It serves as a reminder of the potential risks associated with these products and highlights the need for improved regulations and safety standards in the baby formula industry.
VI. Symptoms of NEC
Necrotizing enterocolitis (NEC) is a serious and potentially life-threatening condition that can affect premature infants. The condition is characterized by inflammation and damage to the intestinal lining, which can cause a range of symptoms.
Some of the most common symptoms of NEC include:
- Abdominal swelling or distension
- Feeding intolerance or reluctance to eat
- Vomiting or spitting up
- Bloody stools or diarrhea
- Lethargy or decreased activity
- Temperature instability (either fever or hypothermia)
It is important to note that not all infants with NEC will exhibit all of these symptoms. Some infants may only exhibit mild symptoms, while others may have more severe symptoms that require immediate medical attention.
Early detection and treatment of NEC is essential for the best possible outcome. Treatment typically involves stopping oral feedings, providing intravenous fluids and nutrition, and monitoring for signs of infection or other complications. In severe cases, surgery may be required to remove damaged portions of the intestine.
Parents and healthcare providers should be aware of the symptoms of NEC and seek immediate medical attention if they suspect that an infant may be affected. Early intervention and treatment can help to reduce the risk of serious complications and improve the long-term outcome for infants with NEC.
VII. Enfamil Lawsuit
Enfamil is another popular brand of baby formula that has been linked to cases of necrotizing enterocolitis (NEC) in infants. However, to date, there have been no lawsuits specifically targeting Enfamil for its role in causing NEC in infants.
In 2018, there was a voluntary recall of one type of Enfamil baby formula due to concerns about possible contamination with the bacteria that can cause NEC. The recall was issued out of an abundance of caution, and there were no reported cases of illness or injury associated with the product.
Enfamil has faced criticism from some parents and consumer advocacy groups for its marketing practices and the composition of its products. However, the company has not faced any major legal action related to its baby formula.
Enfamil has stated that the safety and quality of its products are its top priority, and that it works closely with regulatory agencies and healthcare providers to ensure that its products are safe and effective for infants. The company has also made changes to its product formulations and packaging in response to concerns from consumers and healthcare professionals.
Despite the lack of legal action against Enfamil, the company's products remain under scrutiny from some parents and healthcare professionals who are concerned about the potential risks associated with baby formula consumption. It is important for parents to carefully consider the risks and benefits of using baby formula, and to discuss any concerns with their healthcare provider.
VIII. Baby Formula Industry Overview
The baby formula industry is a multi-billion dollar global market that provides an essential source of nutrition for infants who are unable to breastfeed. However, the industry has faced significant scrutiny and controversy over the years, particularly in relation to issues of safety and regulation.
One notable aspect of the baby formula industry is that the United States does not import any baby formula products. This is due in part to strict regulations imposed by the U.S. Food and Drug Administration (FDA), which require all baby formula sold in the United States to meet specific safety and quality standards. Additionally, many U.S.-based manufacturers of baby formula have facilities located in other countries, which allows them to produce and distribute their products globally while still meeting FDA regulations.
The biggest suppliers of baby formula globally include companies such as Nestle, Danone, and Mead Johnson, among others. These companies have a significant presence in countries around the world and produce a wide range of baby formula products to meet the diverse needs of consumers.
Several countries are also major manufacturers of baby formula products, including China, the United States, and the Netherlands. China is the largest producer of baby formula in the world, with several major companies based in the country. The United States is also a significant manufacturer of baby formula, with companies such as Abbott Laboratories, Mead Johnson, and Nestle operating major production facilities in the country.
Overall, the baby formula industry plays a critical role in providing nutrition for infants who are unable to breastfeed. However, concerns about safety and regulation continue to be a major issue for consumers and healthcare professionals alike. It is important for parents to carefully consider the risks and benefits of using baby formula, and to discuss any concerns with their healthcare provider.
IX. Corn Syrup in Baby Formula
Corn syrup is a common ingredient in many baby formula products, often used as a source of carbohydrates and to provide sweetness. However, the use of corn syrup in baby formula has been a topic of controversy, particularly in relation to concerns about the potential health risks associated with consuming large amounts of added sugars.
One of the main reasons for the use of corn syrup in baby formula is to provide a source of carbohydrates, which are an essential nutrient for infant growth and development. Corn syrup is an easily digestible source of carbohydrates and can help provide a consistent source of energy for growing infants. Additionally, corn syrup is often used in baby formula as a sweetener to improve taste, which can help encourage infants to drink formula and get the nutrition they need.
Despite its widespread use, there are concerns about the potential health risks associated with consuming large amounts of corn syrup, particularly in relation to issues such as obesity and diabetes. Some experts argue that excessive consumption of added sugars in infancy may increase the risk of these and other health problems later in life.
There are alternatives to corn syrup that can be used in baby formula, including lactose and various types of vegetable-based sweeteners. Lactose is a naturally occurring sugar found in breast milk and is commonly used in baby formula products as a carbohydrate source. Vegetable-based sweeteners such as glucose syrup and maltodextrin are also sometimes used in baby formula products as an alternative to corn syrup.
Overall, the use of corn syrup in baby formula remains a controversial issue, with concerns about the potential health risks associated with excessive consumption of added sugars. It is important for parents to carefully consider the ingredients in baby formula products and to discuss any concerns with their healthcare provider.
X. Conclusion
In conclusion, the potential link between necrotizing enterocolitis (NEC) and baby formula consumption has been a topic of concern for many parents and healthcare providers. The NEC lawsuit has shed light on the potential dangers of certain baby formula products and the importance of early detection and treatment of NEC symptoms.
The settlement for the baby formula lawsuit and the class action lawsuit against Similac have also brought attention to the need for improved regulations and safer baby formula options. It is important for parents to carefully consider the ingredients in baby formula products and to discuss any concerns with their healthcare provider.
Symptoms of NEC can include abdominal distention, feeding intolerance, and bloody stools. Early detection and treatment can improve outcomes for infants with NEC.
It is essential that manufacturers prioritize the safety of their products and take steps to reduce the risk of harm to infants. Additionally, regulatory agencies should take a more active role in monitoring the baby formula industry and enforcing regulations to protect infants from potential harm.
Ultimately, parents and healthcare providers must remain vigilant and informed about the potential risks associated with baby formula consumption and work together to ensure the safety and well-being of infants.
